<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40676905</PMID><DateCompleted><Year>2025</Year><Month>08</Month><Day>06</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>15</Issue><PubDate><Year>2025</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Sex-Stratified Long-Term Outcome After Percutaneous Coronary Intervention: A&#xa0;Pooled Analysis of the SORT OUT All-Comer Trials.</ArticleTitle><Pagination><StartPage>e039758</StartPage><MedlinePgn>e039758</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e039758</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.124.039758</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Currently, the sex-differentiated outcome after percutaneous coronary intervention (PCI) favors male sex in most studies. In this study, we aimed to investigate the age-adjusted impact of sex on long-term outcome.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study was an observational, prospective, multicenter, cohort study with pooling of 5-year results of the randomized controlled all-comer stent trials SORT OUT (Scandinavian Organization for Randomized Trials With Clinical Outcome) III, V, VI, VII, VIII, and IX conducted from 2006 to 2017. All patients were followed for 5&#x2009;years. The predefined main outcome was a major adverse cardiac event (MACE); a composite end point comprising all-cause death, spontaneous myocardial infarction, and target lesion revascularization assessed by a clinical event committee. MACE difference across sex was assessed by incidence rate ratios at 5&#x2009;years adjusted for age and predefined risk factors.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 15&#x2009;242 patients (women, 3729 [24.5%]) with a mean age of 67.8&#xb1;11.0&#x2009;years were included in the study, with 0.2% lost to follow-up. Compared with men, women were older (women, 67.8&#xb1;11.0 years; men, 64.8&#xb1;10.7&#x2009;years), had more hypertension and dyslipidemia but less previous MI and revascularization. MACEs occurred in 747 (21.8%) of the women and 2196 (20.5%) of the men at 5&#x2009;years (unadjusted incidence rate ratio, 1.07 [95% CI, 0.98-1.16]; and adjusted incidence rate ratio, 0.91 [95% CI, 0.84-0.99]). Female sex was not associated with an increased risk in any of the individual MACE components.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Female sex was not associated with a poorer long-term outcome than male sex after treatment for coronary artery disease with percutaneous coronary intervention in MACEs or any of the individual components.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Holck</LastName><ForeName>Emil N</ForeName><Initials>EN</Initials><Identifier Source="ORCID">0009-0009-6697-1073</Identifier><AffiliationInfo><Affiliation>Department of Cardiology Aarhus University Hospital Aarhus N Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Health Aarhus University Aarhus N Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Westra</LastName><ForeName>Jelmer</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-1926-0844</Identifier><AffiliationInfo><Affiliation>Department of Cardiology Aarhus University Hospital Aarhus N Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jakobsen</LastName><ForeName>Lars</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-2522-9253</Identifier><AffiliationInfo><Affiliation>Department of Cardiology Aarhus University Hospital Aarhus N Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eftekhari</LastName><ForeName>Ashkan</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2871-8279</Identifier><AffiliationInfo><Affiliation>Department of Cardiology Aalborg University Hospital Aalborg Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freeman</LastName><ForeName>Phillip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Cardiology Aalborg University Hospital Aalborg Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kahlert</LastName><ForeName>Johnny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Epidemiology Aarhus University Hospital Aarhus N Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lassen</LastName><ForeName>Jens F</ForeName><Initials>JF</Initials><Identifier Source="ORCID">0000-0001-7972-9192</Identifier><AffiliationInfo><Affiliation>Department of Cardiology Odense University Hospital Odense C Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jensen</LastName><ForeName>Lisette O</ForeName><Initials>LO</Initials><Identifier Source="ORCID">0000-0002-4838-2429</Identifier><AffiliationInfo><Affiliation>Department of Cardiology Odense University Hospital Odense C Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department Of Clinical Research University of Southern Denmark Odense M Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christiansen</LastName><ForeName>Evald H</ForeName><Initials>EH</Initials><Identifier Source="ORCID">0000-0002-8740-4862</Identifier><AffiliationInfo><Affiliation>Department of Cardiology Aarhus University Hospital Aarhus N Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Health Aarhus University Aarhus N Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>07</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronary artery disease</Keyword><Keyword MajorTopicYN="N">drug&#x2010;eluting stents</Keyword><Keyword MajorTopicYN="N">percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">sex difference</Keyword></KeywordList><CoiStatement>E.N.H. received institutional grants from Asahi Corp., Phillips Corp., and Orbus Neich Corp. E.H.C. received institutional grants from Asahi Corp., Phillips Corp., Orbus Neich Corp., and Abbott Vascular. L.O.J. received unrestricted research grants to her institution from Biotronik, Biosensors, and Orbus Neich.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>8</Month><Day>6</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>6</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>7</Month><Day>18</Day><Hour>2</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>7</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40676905</ArticleId><ArticleId IdType="pmc">PMC12449920</ArticleId><ArticleId IdType="doi">10.1161/JAHA.124.039758</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990&#x2013;2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204&#x2013;1222. doi: 10.1016/S0140-6736(20)30925-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30925-9</ArticleId><ArticleId IdType="pmc">PMC7567026</ArticleId><ArticleId IdType="pubmed">33069326</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Yin F, Fan C, Wang Z. Gender difference in clinical outcomes of the patients with coronary artery disease after percutaneous coronary intervention: a systematic review and meta&#x2010;analysis. Medicine (Baltimore). 2018;97:e11644. doi: 10.1097/MD.0000000000011644</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000011644</ArticleId><ArticleId IdType="pmc">PMC6078653</ArticleId><ArticleId IdType="pubmed">30045311</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosmidou I, Leon MB, Zhang Y, Serruys PW, von Birgelen C, Smits PC, Ben&#x2010;Yehuda O, Redfors B, Madhavan MV, Maehara A, et&#xa0;al. Long&#x2010;term outcomes in women and men following percutaneous coronary intervention. J Am Coll Cardiol. 2020;75:1631&#x2013;1640. doi: 10.1016/j.jacc.2020.01.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.01.056</ArticleId><ArticleId IdType="pubmed">32273029</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlan JJ, Raber L, Brugaletta S, Kufner S, Maeng M, Jensen LO, Ortega&#x2010;Paz L, Bar S, Laugwitz KL, Madsen M, et&#xa0;al. Sex differences in 10&#x2010;year outcomes after percutaneous coronary intervention with drug&#x2010;eluting stents: insights from the DECADE cooperation. Circulation. 2023;147:575&#x2013;585. doi: 10.1161/CIRCULATIONAHA.122.062049</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.122.062049</ArticleId><ArticleId IdType="pubmed">36780380</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy AC, Dinh D, Koshy AN, Lefkovits J, Clark DJ, Zaman S, Duffy SJ, Brennan A, Reid C, Yudi MB, et&#xa0;al. Comparison of long&#x2010;term outcomes in men versus women undergoing percutaneous coronary intervention. Am J Cardiol. 2021;153:1&#x2013;8. doi: 10.1016/j.amjcard.2021.05.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2021.05.013</ArticleId><ArticleId IdType="pubmed">34238448</ArticleId></ArticleIdList></Reference><Reference><Citation>Gul B, Shah T, Head SJ, Chieffo A, Hu X, Li F, Brackett A, Gesick C, Bisarya PK, Lansky A. Revascularization options for females with multivessel coronary artery disease: a meta&#x2010;analysis of randomized controlled trials. JACC Cardiovasc Interv. 2020;13:1009&#x2013;1010. doi: 10.1016/j.jcin.2019.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2019.12.036</ArticleId><ArticleId IdType="pubmed">32113933</ArticleId></ArticleIdList></Reference><Reference><Citation>Serruys PW, Cavalcante R, Collet C, Kappetein AP, Sabik JF 3rd, Banning AP, Taggart DP, Sabate M, Pomar J, Boonstra PW, et&#xa0;al. Outcomes after coronary stenting or bypass surgery for men and women with unprotected left Main disease: the EXCEL trial. JACC Cardiovasc Interv. 2018;11:1234&#x2013;1243. doi: 10.1016/j.jcin.2018.03.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2018.03.051</ArticleId><ArticleId IdType="pubmed">29976359</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara H, Takahashi K, van Klaveren D, Wang R, Garg S, Ono M, Kawashima H, Gao C, Mack M, Holmes DR, et&#xa0;al. Sex differences in all&#x2010;cause mortality in the decade following complex coronary revascularization. J Am Coll Cardiol. 2020;76:889&#x2013;899. doi: 10.1016/j.jacc.2020.06.066</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.06.066</ArticleId><ArticleId IdType="pubmed">32819461</ArticleId></ArticleIdList></Reference><Reference><Citation>McEntegart MB, Holm NR, Lindsay MM, Oldroyd KG, M&#xe4;kikallio T, Hildick&#x2010;Smith D, Erglis A, Kellerth T, Davidavicius G, Menown IBA, et&#xa0;al. Sex&#x2010;specific clinical outcomes after treatment of left main coronary artery disease. A NOBLE substudy. J Soc Cardiovasc Angiogr Interv. 2022;1:100338. doi: 10.1016/j.jscai.2022.100338</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jscai.2022.100338</ArticleId><ArticleId IdType="pmc">PMC11308852</ArticleId><ArticleId IdType="pubmed">39131931</ArticleId></ArticleIdList></Reference><Reference><Citation>Solola Nussbaum S, Henry S, Yong CM, Daugherty SL, Mehran R, Poppas A. Sex&#x2010;specific considerations in the presentation, diagnosis, and management of ischemic heart disease: JACC Focus Seminar 2/7. J Am Coll Cardiol. 2022;79:1398&#x2013;1406. doi: 10.1016/j.jacc.2021.11.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2021.11.065</ArticleId><ArticleId IdType="pmc">PMC9009217</ArticleId><ArticleId IdType="pubmed">35393022</ArticleId></ArticleIdList></Reference><Reference><Citation>DeFilippis EM, Collins BL, Singh A, Biery DW, Fatima A, Qamar A, Berman AN, Gupta A, Cawley M, Wood MJ, et&#xa0;al. Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG&#x2010;MI registry. Eur Heart J. 2020;41:4127&#x2013;4137. doi: 10.1093/eurheartj/ehaa662</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa662</ArticleId><ArticleId IdType="pmc">PMC7700756</ArticleId><ArticleId IdType="pubmed">33049774</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawano M, Lu Y, Caraballo C, Mahajan S, Dreyer R, Lichtman JH, D'Onofrio G, Spatz E, Khera R, Onuma O, et&#xa0;al. Sex difference in outcomes of acute myocardial infarction in young patients. J Am Coll Cardiol. 2023;81:1797&#x2013;1806. doi: 10.1016/j.jacc.2023.03.383</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2023.03.383</ArticleId><ArticleId IdType="pubmed">37137590</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilmot KA, O'Flaherty M, Capewell S, Ford ES, Vaccarino V. Coronary heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women. Circulation. 2015;132:997&#x2013;1002. doi: 10.1161/CIRCULATIONAHA.115.015293</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.015293</ArticleId><ArticleId IdType="pmc">PMC4828724</ArticleId><ArticleId IdType="pubmed">26302759</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan GA, Dweck MR, Galbraith M, et&#xa0;al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720&#x2013;3826. doi: 10.1093/eurheartj/ehad191</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehad191</ArticleId><ArticleId IdType="pubmed">37622654</ArticleId></ArticleIdList></Reference><Reference><Citation>Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck&#x2010;Brentano C, Prescott E, Storey RF, Deaton C, Cuisset T, et&#xa0;al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407&#x2013;477. doi: 10.1093/eurheartj/ehz425</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz425</ArticleId><ArticleId IdType="pubmed">31504439</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, Abildgaard U, Christiansen EH, Engstrom T, Krusell LR, et&#xa0;al. Efficacy and safety of zotarolimus&#x2010;eluting and sirolimus&#x2010;eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet. 2010;375:1090&#x2013;1099. doi: 10.1016/S0140-6736(10)60208-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)60208-5</ArticleId><ArticleId IdType="pubmed">20231034</ArticleId></ArticleIdList></Reference><Reference><Citation>Christiansen EH, Jensen LO, Thayssen P, Tilsted HH, Krusell LR, Hansen KN, Kaltoft A, Maeng M, Kristensen SD, Botker HE, et&#xa0;al. Biolimus&#x2010;eluting biodegradable polymer&#x2010;coated stent versus durable polymer&#x2010;coated sirolimus&#x2010;eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non&#x2010;inferiority trial. Lancet. 2013;381:661&#x2013;669. doi: 10.1016/S0140-6736(12)61962-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(12)61962-X</ArticleId><ArticleId IdType="pubmed">23374649</ArticleId></ArticleIdList></Reference><Reference><Citation>Raungaard B, Jensen LO, Tilsted HH, Christiansen EH, Maeng M, Terkelsen CJ, Krusell LR, Kaltoft A, Kristensen SD, Botker HE, et&#xa0;al. Zotarolimus&#x2010;eluting durable&#x2010;polymer&#x2010;coated stent versus a biolimus&#x2010;eluting biodegradable&#x2010;polymer&#x2010;coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non&#x2010;inferiority trial. Lancet. 2015;385:1527&#x2013;1535. doi: 10.1016/S0140-6736(14)61794-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61794-3</ArticleId><ArticleId IdType="pubmed">25601789</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen LO, Thayssen P, Maeng M, Ravkilde J, Krusell LR, Raungaard B, Junker A, Terkelsen CJ, Veien KT, Villadsen AB, et&#xa0;al. Randomized comparison of a biodegradable polymer ultrathin strut Sirolimus&#x2010;eluting stent with a biodegradable polymer biolimus&#x2010;eluting stent in patients treated with percutaneous coronary intervention: the SORT OUT VII trial. Circ Cardiovasc Interv. 2016;9:e003610. doi: 10.1161/CIRCINTERVENTIONS.115.003610</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCINTERVENTIONS.115.003610</ArticleId><ArticleId IdType="pubmed">27412869</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeng M, Christiansen EH, Raungaard B, Kahlert J, Terkelsen CJ, Kristensen SD, Carstensen S, Aaroe J, Jensen SE, Villadsen AB, et&#xa0;al. Everolimus&#x2010;eluting versus biolimus&#x2010;eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: a randomized noninferiority trial with 1&#x2010;year follow&#x2010;up (SORT OUT VIII trial). JACC Cardiovasc Interv. 2019;12:624&#x2013;633. doi: 10.1016/j.jcin.2018.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcin.2018.12.036</ArticleId><ArticleId IdType="pubmed">30947936</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen LO, Maeng M, Raungaard B, Kahlert J, Ellert J, Jakobsen L, Villadsen AB, Veien KT, Kristensen SD, Ahlehoff O, et&#xa0;al. Randomized comparison of the polymer&#x2010;free biolimus&#x2010;coated BioFreedom stent with the ultrathin strut biodegradable polymer sirolimus&#x2010;eluting orsiro stent in an all&#x2010;comers population treated with percutaneous coronary intervention: the SORT OUT IX trial. Circulation. 2020;141:2052&#x2013;2063. doi: 10.1161/CIRCULATIONAHA.119.040241</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.040241</ArticleId><ArticleId IdType="pubmed">32434381</ArticleId></ArticleIdList></Reference><Reference><Citation>Thuesen L, Jensen LO, Tilsted HH, Maeng M, Terkelsen C, Thayssen P, Ravkilde J, Christiansen EH, Botker HE, Madsen M, et&#xa0;al. Event detection using population&#x2010;based health care databases in randomized clinical trials: a novel research tool in interventional cardiology. Clin Epidemiol. 2013;5:357&#x2013;361. doi: 10.2147/CLEP.S44651</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S44651</ArticleId><ArticleId IdType="pmc">PMC3782507</ArticleId><ArticleId IdType="pubmed">24068874</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt M, Maeng M, Jakobsen CJ, Madsen M, Thuesen L, Nielsen PH, Botker HE, Sorensen HT. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clin Epidemiol. 2010;2:137&#x2013;144. doi: 10.2147/clep.s10190</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/clep.s10190</ArticleId><ArticleId IdType="pmc">PMC2943184</ArticleId><ArticleId IdType="pubmed">20865111</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundboll J, Adelborg K, Munch T, Froslev T, Sorensen HT, Botker HE, Schmidt M. Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study. BMJ Open. 2016;6:e012832. doi: 10.1136/bmjopen-2016-012832</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-012832</ArticleId><ArticleId IdType="pmc">PMC5129042</ArticleId><ArticleId IdType="pubmed">27864249</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; Writing Group on the Joint ESCAAHAWHFTFftUDoMI , Thygesen K, Alpert JS, White HD, et&#xa0;al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33:2551&#x2013;2567. doi: 10.1093/eurheartj/ehs184</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehs184</ArticleId><ArticleId IdType="pubmed">22922414</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD, Group ESCSD . Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019;40:237&#x2013;269. doi: 10.1093/eurheartj/ehy462</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy462</ArticleId><ArticleId IdType="pubmed">30165617</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia&#x2010;Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel MA, van Es GA, Zuckerman B, et&#xa0;al. Standardized end point definitions for coronary intervention trials: the Academic Research Consortium&#x2010;2 consensus document. Eur Heart J. 2018;39:2192&#x2013;2207. doi: 10.1093/eurheartj/ehy223</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy223</ArticleId><ArticleId IdType="pubmed">29897428</ArticleId></ArticleIdList></Reference><Reference><Citation>Holck EN, Winther NS, Mogensen LJ, Christiansen EH. Chronic total occlusion is not a risk factor for mortality in patients with successful percutaneous coronary intervention: a cohort study. J Am Heart Assoc. 2023;12:e030989. doi: 10.1161/JAHA.123.030989</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.123.030989</ArticleId><ArticleId IdType="pmc">PMC10757529</ArticleId><ArticleId IdType="pubmed">37830355</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M, Alexander JH, Sandner S, Harik L, Kim J, Stone GW, Rahouma M, O'Gara P, Bhatt DL, Redfors B. Outcomes by sex in the international study of comparative health effectiveness with medical and invasive approaches (ISCHEMIA) trial. EuroIntervention. 2024;20:551&#x2013;560. doi: 10.4244/EIJ-D-24-00011</Citation><ArticleIdList><ArticleId IdType="doi">10.4244/EIJ-D-24-00011</ArticleId><ArticleId IdType="pmc">PMC11067519</ArticleId><ArticleId IdType="pubmed">38444364</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X, Chandramouli C, Allocco B, Gong E, Lam CSP, Yan LL. Women's participation in cardiovascular clinical trials from 2010 to 2017. Circulation. 2020;141:540&#x2013;548. doi: 10.1161/CIRCULATIONAHA.119.043594</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.043594</ArticleId><ArticleId IdType="pubmed">32065763</ArticleId></ArticleIdList></Reference><Reference><Citation>Potts J, Sirker A, Martinez SC, Gulati M, Alasnag M, Rashid M, Kwok CS, Ensor J, Burke DL, Riley RD, et&#xa0;al. Persistent sex disparities in clinical outcomes with percutaneous coronary intervention: insights from 6.6 million PCI procedures in the United States. PLoS One. 2018;13:e0203325. doi: 10.1371/journal.pone.0203325</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0203325</ArticleId><ArticleId IdType="pmc">PMC6122817</ArticleId><ArticleId IdType="pubmed">30180201</ArticleId></ArticleIdList></Reference><Reference><Citation>Sambola A, Blanco BGD, Kunadian V, Vogel B, Chieffo A, Vidal M, Ratcovich H, Botti G, Wilkinson C, Mehran R. Sex&#x2010;based differences in percutaneous coronary intervention outcomes in patients with Ischaemic heart disease. Eur Cardiol Rev. 2023;18(e06):2023. doi: 10.15420/ecr.2022.24</Citation><ArticleIdList><ArticleId IdType="doi">10.15420/ecr.2022.24</ArticleId><ArticleId IdType="pmc">PMC10345982</ArticleId><ArticleId IdType="pubmed">37456769</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaudino M, Di Franco A, Alexander JH, Bakaeen F, Egorova N, Kurlansky P, Boening A, Chikwe J, Demetres M, Devereaux PJ, et&#xa0;al. Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data. Eur Heart J. 2021;43:18&#x2013;28. doi: 10.1093/eurheartj/ehab504</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab504</ArticleId><ArticleId IdType="pmc">PMC8851663</ArticleId><ArticleId IdType="pubmed">34338767</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>